Skip to main content
. 2020 Aug 10;9(9):17. doi: 10.1167/tvst.9.9.17

Table 1.

Direct Costs

Entry
Voretigene-Neparvovec per eye 410,550
Pharmacy per eye 2000
DRG G18Z reimbursement per eye 2840
Outpatient reimbursement per quarter 220
Direct costs year 1 831,660
Direct costs year n 220

Direct costs per year are added for the treatment of both eyes. DRG, diagnosis related group.